US Broker Ratings

Viemed Healthcare, Inc. (VMD) Stock Analysis: A 91% Potential Upside Makes This Healthcare Play Worth Watching

Viemed Healthcare, Inc. (NASDAQ: VMD) presents an intriguing proposition for investors seeking opportunities within the healthcare sector, particularly in the niche of medical devices. As a provider of home medical..

Nerdy Inc. (NRDY) Stock Analysis: Uncovering a 55.85% Potential Upside in the Tech Sector

Nerdy Inc. (NRDY), a prominent player in the technology sector, is making waves with its innovative approach to online learning. Headquartered in Saint Louis, Missouri, Nerdy Inc. operates a sophisticated..

Vanda Pharmaceuticals Inc. (VNDA) Investor Outlook: Analyzing the 168% Potential Upside

Investors focused on the biotechnology sector might find Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) a compelling asset to consider. With a market capitalization of $278.9 million, this U.S.-based biopharmaceutical company is..

Zhengye Biotechnology Holding L (ZYBT) Stock Analysis: Navigating the Challenges in the Veterinary Vaccine Market

Zhengye Biotechnology Holding Limited (ZYBT), a player in the healthcare sector, specifically within the specialty and generic drug manufacturing industry, is carving its niche in the veterinary vaccine market in..

Cidara Therapeutics, Inc. (CDTX) Investor Outlook: Potential 25.81% Upside with Strategic Biotech Innovations

Cidara Therapeutics, Inc. (NASDAQ: CDTX) is making waves in the biotechnology sector, offering investors a glimpse into a promising future with its groundbreaking developments in targeted therapies for serious diseases...

Materialise NV (MTLS) Stock Analysis: A Look at the 81% Potential Upside

Materialise NV (MTLS), a Belgian-based company specializing in additive manufacturing and medical software, presents a compelling investment opportunity for those interested in the technology sector. Despite recent challenges in revenue,..

ClearPoint Neuro Inc. (CLPT) Stock Analysis: A 182% Upside Potential Sparks Investor Interest

ClearPoint Neuro Inc. (NASDAQ: CLPT) stands at a unique crossroads in the healthcare sector, offering compelling opportunities for investors intrigued by its innovative medical device technologies. As a company specializing..

Olema Pharmaceuticals, Inc. (OLMA) Stock Analysis: 297% Upside Potential with Strong Analyst Buy Ratings

Olema Pharmaceuticals, Inc. (NASDAQ: OLMA), a clinical-stage biopharmaceutical company, is capturing attention in the biotechnology sector with its promising therapeutic developments in women’s cancers. The company, headquartered in San Francisco,..

Phathom Pharmaceuticals, Inc. (PHAT) Stock Analysis: Exploring a 79.92% Upside Potential in the Biotech Sector

Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT), a key player in the biotechnology sector, presents a compelling opportunity for investors with its strategic focus on gastrointestinal treatments. With a market capitalization of..

AMTD Digital Inc. (HKD) Stock Analysis: Navigating the Challenges and Opportunities in the Digital Solutions Sector

AMTD Digital Inc. (NYSE: HKD) stands at a pivotal juncture in the ever-evolving technology sector, with its diverse portfolio encompassing digital solutions, media, entertainment services, and VIP offerings. While headquartered..

Mereo BioPharma Group plc (MREO): Analyst Ratings Suggest Over 300% Upside Potential

For investors with an appetite for high-risk, high-reward opportunities, Mereo BioPharma Group plc (NASDAQ: MREO) offers a compelling case. Specializing in the development and commercialization of therapeutics targeting oncology and..

Heron Therapeutics, Inc. (HRTX) Stock Analysis: Exploring a 257% Potential Upside in the Biotechnology Sector

Heron Therapeutics, Inc. (NASDAQ: HRTX) is garnering attention from investors with its impressive potential upside of 257.14%. Operating within the healthcare sector, the company specializes in biotechnology, focusing on the..

Rigel Pharmaceuticals, Inc. (RIGL) Stock Analysis: Unpacking the 176% Revenue Growth and Robust Pipeline

Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL), a pioneer in the biotechnology sector, is capturing the attention of investors with its remarkable 176% revenue growth. Based in South San Francisco, this company..

Canopy Growth Corporation (CGC) Stock Analysis: Navigating a Challenging Market with Strategic Positioning

Canopy Growth Corporation (NASDAQ: CGC) is a prominent player in the healthcare sector, specifically within the niche of drug manufacturers specializing in cannabis and related products. Headquartered in Smiths Falls,..

Applovin Corporation (APP) Stock Analysis: Evaluating the Robust Growth and Market Position

Applovin Corporation (NASDAQ: APP) has been making significant waves in the communication services sector, specifically within the advertising agencies industry. Headquartered in Palo Alto, California, Applovin has established itself as..

Absci Corporation (ABSI) Stock Analysis: Potential 241% Upside Makes This AI-Driven Biotech a Compelling Play

Absci Corporation (NASDAQ: ABSI) is an intriguing player in the biotechnology sector, leveraging cutting-edge artificial intelligence (AI) to revolutionize drug creation. Despite facing some financial turbulence, the company’s innovative approach..

Cytek Biosciences, Inc. (CTKB) Stock Analysis: Unveiling a 30% Upside Potential in the Medical Devices Arena

Cytek Biosciences, Inc. (NASDAQ: CTKB) stands as a notable player in the healthcare sector, specifically within the medical devices industry. Headquartered in Fremont, California, Cytek Biosciences has carved out a..

Quantum-Si (QSI) Stock Analysis: Exploring a 149% Potential Upside in Next-Gen Protein Sequencing

Quantum-Si Incorporated (NASDAQ: QSI), a pioneering force in the healthcare sector’s medical devices industry, is making waves with its innovative approach to protein sequencing. Headquartered in Branford, Connecticut, this life..

Aura Biosciences, Inc. (AURA) Stock Analysis: Exploring a 231% Potential Upside in the Biotech Sector

Aura Biosciences, Inc. (NASDAQ: AURA) presents a compelling opportunity for investors looking to capitalize on the burgeoning biotechnology sector. Headquartered in Boston, Massachusetts, this clinical-stage biotech company is at the..

Neurogene Inc. (NGNE): Analyst Consensus Highlights 138% Potential Upside for Biotech Innovator

In the ever-evolving landscape of biotechnology, Neurogene Inc. (NASDAQ: NGNE) stands out as a company with significant potential upside, according to recent analyst ratings. With a market capitalization of $283.58..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds